Improved predictions of total kidney volume growth rate in ADPKD using two-parameter least squares fitting

Zhongxiu Hu1, Arman Sharbatdaran1, Xinzi He1

  • 1Department of Radiology, Weill Cornell Medicine, New York, 10022, USA.

Scientific Reports
|June 14, 2024
PubMed

Insights

The Mayo Imaging Classification (MIC) may be less accurate for predicting kidney growth in autosomal dominant polycystic kidney disease (ADPKD) patients with multiple scans. Advanced fitting methods show improved accuracy, particularly for males and those with PKD2 mutations.

Area of Science:

  • Nephrology
  • Radiology
  • Genetics

Background:

  • Autosomal dominant polycystic kidney disease (ADPKD) is a genetic disorder characterized by kidney cyst formation.
  • The Mayo Imaging Classification (MIC) predicts kidney growth using a single MRI/CT scan, assuming exponential growth.
  • Optimal methods for combining multiple imaging scans to improve growth prediction in ADPKD are not well-defined.

Purpose of the Study:

  • To evaluate the accuracy of MIC in predicting kidney growth trajectory in ADPKD patients with longitudinal imaging data.
  • To compare MIC predictions with alternative methods, including least squares fitting, using multiple available scans.
  • To identify patient subgroups where MIC performance may be suboptimal.

Main Methods:

  • Retrospective analysis of ADPKD subjects with at least 8 years of imaging follow-up (mean 11 years).
  • Established ground truth kidney growth trajectories from serial MRI/CT scans.
  • Compared annualized mean absolute error of MIC predictions against 1- and 2-parameter least squares fitting models.

Main Results:

  • 2-parameter least squares fitting demonstrated superior accuracy over MIC in predicting total kidney volume growth rate when 4 measurements were available.
  • With 3 measurements, a combination of MIC and averaging showed improvement, but 2-parameter fitting remained more accurate.
  • Male sex and PKD2 mutations were associated with poorer MIC performance.

Conclusions:

  • In ADPKD patients with 3 or more imaging scans, 2-parameter least squares fitting provides more accurate kidney volume growth rate predictions than MIC.
  • MIC's predictive accuracy is particularly limited in males and individuals with PKD2 mutations.
  • Longitudinal data and advanced fitting methods can enhance growth prediction accuracy in ADPKD management.

Related Concept Videos

Determination of Renal Drug Clearance: Graphical and Midpoint Methods01:07

Determination of Renal Drug Clearance: Graphical and Midpoint Methods

Renal clearance, a crucial parameter in pharmacokinetics, can be determined using two different methods: the graphical method and the midpoint method. These methods provide insights into the rate of drug excretion by the kidneys and aid in assessing renal function.
The graphical method involves plotting the rate of drug excretion in urine against the plasma drug concentration. By analyzing the graph, the clearance can be calculated and obtained. Drugs rapidly excreted by the kidneys exhibit a...
One-Compartment Open Model: Urinary Excretion Data and Determination of k01:11

One-Compartment Open Model: Urinary Excretion Data and Determination of k

The one-compartment open model leverages urinary excretion data to estimate renal clearance, which gauges the kidney's capacity to expel a drug. This method offers several benefits, including directly measuring drug elimination and assessing the kidney's contribution to overall drug clearance. However, this approach has limitations. It assumes sole renal excretion of the drug, which is not true for all drugs. Accurate urinary excretion and plasma drug concentration measurement can also be...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate01:25

Drug Dosing in Renal Diseases: Measurement of Glomerular Filtration Rate

The glomerular filtration rate (GFR) is a critical indicator of kidney health, reflecting how well the kidneys filter blood. Changes in GFR can signal potential kidney impairment, necessitating accurate measurement methods to monitor kidney function effectively.Various molecules can serve as markers for GFR measurement, with the ideal marker meeting several specific criteria. It must freely filter at the glomerulus, avoid reabsorption or secretion by the renal tubules, remain unmetabolized, not...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant01:25

Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant

In patients with renal disease, dosage adjustments are necessary to maintain therapeutic plasma drug concentrations and prevent toxicity or subtherapeutic exposure. Renal impairment alters drug pharmacokinetics, especially in conditions like uremia, where changes such as prolonged elimination half-life and altered apparent volume of distribution can significantly affect drug disposition. These changes require careful modification of the dosing regimen to achieve the desired clinical...